Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

Presentation Live Valves 2019

Aortic Insufficiency: Repair vs. Replacement?

Presenter: Evaldas Girdauskas

December 10, 2019

Presentation TCT Abstracts Posters 2019

Minimally Invasive Allograft Implantation in Elective Aortic Valve Surgery: Aortic Homograft New Implantation Technique and Ministernotomy Ross Procedure

Presenter: Miklós Bitay

September 29, 2019

Presentation EuroPCR 2019

Prosthetic valve endocarditis after transcatheter or surgical AVR with a bioprosthesis Results from the FinnValve registry

Presenter: Noriaki Moriyama

May 21, 2019

Presentation ECHO/IMAGING 2019

Case: 80 yo female with prior AVR

Presenter: Jeremy Thaden

March 23, 2019

Presentation

Valve-in-Valve TAVR vs Redo Surgical AVR for Bioprosthetic Aortic Valve Dysfunction

April 25, 2018

Presentation

Frailty in Older Adults Undergoing AVR:The FRAILTY-AVR Study

July 12, 2017

Presentation TVT 2017

Pitfalls in TAVR for Failing Stentless St. Jude Toronto 27mm Bioprosthetic AVR With Severe Aortic Insufficiency and No Significant Valvular Calcification

Presenter: Shigeru Saito, Jonathon M. White, Johannes Brechtken, MD

June 16, 2017

Presentation

Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR

Presenter: G. Michael Deeb

April 06, 2016

Presentation

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

Presenter: V. Dayan

December 06, 2015

Presentation Aortovascular 2015

Valve-in-Valve TAVR: Changing the approach to initial AVR surgery?

Presenter: Isaac George

September 19, 2015

Presentation Aortovascular 2015

Mechanical AVR and Root Replacement: When indicated?

Presenter: Michael Argenziano

September 19, 2015

Presentation Aortovascular 2015

Conventional AVR and Root Replacement: Bioprosthetic options

Presenter: Wilson Y. Szeto

September 19, 2015

Presentation

Use of Psoas Muscle Size as a Frailty Assessment Tool for Open and Transcatheter AVR

Presenter: Himanshu J. Patel

April 29, 2015

Presentation TCT 2014

Position Statement: TAVR Will Replace Surgical AVR in Low- and Intermediate-Risk Patients: Cath Labs Get Ready!

Presenter: Kishore J. Harjai, Susheel Kodali

September 14, 2014

Presentation TVT 2014

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Presenter: Michael J. Mack

June 07, 2014

Presentation

PARTNER: Bleeding Complications After Surgical AVR Compared with TAVR

Presenter: P. G?n?reux

December 02, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Presenter: Daniel Blackman

October 30, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Presenter: Charles Davidson

October 30, 2013

Presentation TCT 2013

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Presenter: Larry Wood

October 29, 2013

Presentation TCT 2013

The High Frequency and Insidious Consequences of Bleeding Events After TAVR (and Surgical AVR)

Presenter: Philippe Généreux

October 28, 2013

Advertisement

Aortic Insufficiency: Repair vs. Replacement?

Minimally Invasive Allograft Implantation in Elective Aortic Valve Surgery: Aortic Homograft New Implantation Technique and Ministernotomy Ross Procedure

Prosthetic valve endocarditis after transcatheter or surgical AVR with a bioprosthesis Results from the FinnValve registry

Case: 80 yo female with prior AVR

Valve-in-Valve TAVR vs Redo Surgical AVR for Bioprosthetic Aortic Valve Dysfunction

Frailty in Older Adults Undergoing AVR:The FRAILTY-AVR Study

Pitfalls in TAVR for Failing Stentless St. Jude Toronto 27mm Bioprosthetic AVR With Severe Aortic Insufficiency and No Significant Valvular Calcification

Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR

Outcome and Impact of AVR in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis (AS)

Valve-in-Valve TAVR: Changing the approach to initial AVR surgery?

Mechanical AVR and Root Replacement: When indicated?

Conventional AVR and Root Replacement: Bioprosthetic options

Use of Psoas Muscle Size as a Frailty Assessment Tool for Open and Transcatheter AVR

Position Statement: TAVR Will Replace Surgical AVR in Low- and Intermediate-Risk Patients: Cath Labs Get Ready!

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

PARTNER: Bleeding Complications After Surgical AVR Compared with TAVR

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

The High Frequency and Insidious Consequences of Bleeding Events After TAVR (and Surgical AVR)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content